Analyst Reco. Agenus Inc.

Equities

AGEN

US00847G8042

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
16.6 ^USD	+0.24%		+5.80%	+0.25%

May. 16	Agenus Inc. announces FDA Grants Agenus Type B End-Of-Phase 2 Meeting to Discuss Bot/Bal Therapy for Relapsed or Refractory Metastatic Colorectal Cancer	CI
May. 07	Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

B. Riley Securities Trims Agenus' Price Target to $5 From $6 After Model Update, Maintains Buy Rating	Mar. 18	MT
B. Riley Lowers Agenus' Price Target to $6 From $8, Maintains Buy Rating	Nov. 09	MT
Baird Initiates Agenus at Outperform With $8 Price Target	23-06-06	MT
HC Wainwright Assumes Agenus at Buy With $8 Price Target	23-02-28	MT
EF Hutton Starts Agenus With Buy Rating, Sets Price Target at $8.30	22-12-22	MT
EF Hutton Initiates Agenus With Buy Rating, Price Target is $8.3	22-12-08	MT
SMBC Nikko Starts Agenus at Outperform With $5 Price Target	22-09-28	MT
B. Riley Lowers Agenus' Price Target to $8 from $11, Keeps Buy Rating	22-03-03	MT
HC Wainwright Adjusts Agenus' Price Target to $14 from $12, Reiterates Buy Rating	22-03-02	MT
HC Wainwright Starts Agenus at Buy With $12 Price Target	21-12-16	MT
Agenus : Says Cervical Cancer Combination Therapy Shows 'High' Response Rates in Phase 2 Trial	21-09-17	MT
AGENUS : B. Riley Raises Agenus' PT to $12 from $11, Says Continued Regulatory Progress to Drive Stock Price Performance; Keeps Buy Rating	21-09-07	MT
AGENUS : B. Riley Raises Agenus' PT to $11 from $8, Notes Value Accretive Catalysts; Keeps Buy Rating	21-06-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer